Author: Steve Kopczak

• Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
• Setton J, Selenica P, Mukherjee S, Shah R, Pecorari I, McMillan B, Pei IX, Kemel Y, Ceyhan-Birsoy O, Sheehan M, Tkachuk K, Brown DN, Zhang L, Cadoo K, Powell S, Weigelt B, Robson M, Riaz N, Offit K, Reis-Filho JS, Mandelker D.
• NPJ Breast Cancer. 2021 Oct 11;7(1):135. doi: 10.1038/s41523-021-00339-0.

• PMID: 34635660
• PubMed abstract

• Free Full Text

• Study: Genetic testing for inherited mutations may be helpful for all people with advanced or metastatic cancer.
• [No author given]
• FORCE. XRAY. 2021 Sep 30.

• Research news
• Free Full Text

Related:

Original research:

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.

• PMID: 34133209
• PubMed abstract
• Source abstract

• Genetic Testing Challenges in Oncology: BRCA1 Variant Downgraded After Risk-Reducing Surgery.
• Ray T.
• Precision Oncology News. Biomarkers. BRCA. 2021 Sep 29.

• Free Full Text

• Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer.
• Peterlongo P, Figlioli G, Deans AJ, Couch FJ.
• NPJ Breast Cancer. 2021 Sep 28;7(1):130. doi: 10.1038/s41523-021-00338-1.

• PMID: 34584094
• PubMed abstract

• Commentary
• Free PMC article
• Free Full Text

• The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
• Frugtniet B, Morgan S, Murray A, Palmer-Smith S, White R, Jones R, Hanna L, Fuller C, Hudson E, Mullard A, Quinton AE.
• BJOG. 2021 Oct 17. doi: 10.1111/1471-0528.16975. Epub ahead of print

• Source abstract

• Prevalence and Clinical Characterization of BRCA1 and BRCA2 Mutations in Korean Patients with Epithelial Ovarian Cancer.
• Paik ES, Heo EJ, Choi CH, Kim JH, Kim JW, Kim YM, Park SY, Lee JW, Kim JW, Kim BG.
• Cancer Sci. 2021 Oct 17. doi: 10.1111/cas.15166. Epub ahead of print.

• Source abstract

• Free Full Text

• ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
• Mittal A, Pramanik R.
• Ann Surg Oncol. 2021 Oct 15. doi: 10.1245/s10434-021-10880-8. Epub ahead of print.

• PMID: 34654988
• PubMed abstract

• Free Full Text

• Inherited Mutations in Chinese Men With Prostate Cancer.
• Zhu Y, Wei Y, Zeng H, Li Y, Ng CF, Zhou F, He C, Sun G, Ni Y, Chiu PKF, Teoh JYC, Wang B, Pan J, Wan F, Dai B, Qin X, Lin G, Gan H, Wu J, Ye D.
• J Natl Compr Canc Netw. 2021 Oct 15:1-9. doi: 10.6004/jnccn.2021.7010. Epub ahead of print.

• PMID: 34653963
• PubMed abstract
• Source abstract

• Free Full Text

• Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
• Truong H, Sheikh R, Kotecha R, Kemel Y, Reisz PA, Lenis AT, Mehta NN, Khurram A, Joseph V, Mandelker D, Latham A, Ceyhan-Birsoy O, Ladanyi M, Shah NJ, Walsh MF, Voss MH, Lee CH, Russo P, Coleman JA, Hakimi AA, Feldman DR, Stadler ZK, Robson ME, Motzer RJ, Offit K, Patil S, Carlo MI.
• Eur Urol Oncol. 2021 Oct 12:S2588-9311(21)00180-2. doi: 10.1016/j.euo.2021.09.005. Epub ahead of print.

• PMID: 34654685
• PubMed abstract

• Free Full Text

• Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer.
• Jenks S.
• FORCE. Blog. 2021 Oct 12.

• Blog post
• Free Full Text